Skip to main navigation
Logo

Investor Relations

  • About Us
    • History
    • Our Leadership
    • Our Board of Directors
  • Pipeline
    • Mechanism of Action
    • Indications
    • Posters & Presentations
  • For Patients
  • For Investors
    • Overview
    • Stock Information
      • Stock Quote/Chart
    • News & Events
      • News Releases
      • Investor Calendar
      • Presentations
    • Financial Information
      • SEC Filings
    • Corporate Governance
      • Governance Highlights
      • Committee Composition
    • Investor Resources
      • Email Alerts
      • IR Contacts
  • Join Us
  • Contact Us

News Releases

News Releases

Feb 16, 2021
Immunovant Reports Financial Results for the Quarter and Nine Months Ended December 31, 2020
Feb 02, 2021
Immunovant Announces Voluntary Pause in Clinical Dosing of IMVT-1401
Jan 12, 2021
Immunovant Appoints Rita Jain Chief Medical Officer And Provides Corporate Update

Immuno - Toolkits

  • Print Page
  • Email Alerts
  • RSS Feeds
  • IR Contacts
About Us Pipeline Contact Careers

© Immunovant, Inc. | Privacy Policy | Terms of Use